EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.5.4.B9 | Acquired Immunodeficiency Syndrome |
15609224 |
Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 3 2 1 |
3.5.4.B9 | Breast Neoplasms |
23852168 |
Evidence for APOBEC3B mutagenesis in multiple human cancers. |
causal interaction ongoing research therapeutic application unassigned |
3 2 1 0 |
3.5.4.B9 | Carcinogenesis |
28077648 |
Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor. |
causal interaction diagnostic usage ongoing research unassigned |
4 1 2 0 |
3.5.4.B9 | Infections |
18675436 |
APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages. |
therapeutic application unassigned |
1 0 |
3.5.4.B9 | Influenza, Human |
18999897 |
Apobec 3F and apobec 3G have no inhibition and hypermutation effect on the human influenza A virus. |
ongoing research therapeutic application unassigned |
2 1 0 |
3.5.4.B9 | Leukemia |
15254195 |
APOBEC3G targets specific virus species. |
unassigned |
0 |
3.5.4.B9 | Neoplasms |
28077648 |
Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor. |
causal interaction diagnostic usage ongoing research unassigned |
4 1 2 0 |
3.5.4.B9 | Neoplasms |
28646470 |
APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells. |
unassigned |
0 |